Vanda Pharmaceuticals logo

Vanda Pharmaceuticals

VNDA | NASDAQ
Chart Builder DCF Calculator
$3.81
-$0.18 (-4.51%)
At close: Nov 16, 2026, 4:00 PM ET
$3.81
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.51%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
41.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #482/1021 (Top 47%)

Key Statistics

Market Data

Market Cap $230.39M
1D Range
3.74 3.97
52W Range
3.59 9.56

Valuation (TTM)

PE -0.82
PB 1.15
EV/EBITDA -0.69

Valuation (NTM)

Forward PE N/A
Forward PEG 0.16
Price Target $10.00
Loading financial charts...

Profile

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two ...

Sector Healthcare
Industry Biotechnology
Employees 533
IPO Date Apr 12, 2006
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 28, 2026
EPS
-$0.37
Beat +45.75%
REV
$69.82M
Beat +0.89%
Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$10.00
Upside
+162.47%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.